Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

7 Stocks to Buy Down 20% in December

By Will Ashworth, InvestorPlace Contributor
The sell-off at the end of 2018 has made bargains of several great stocks to buy. Look for a turnaround in these 7 names.

Roku Stock Soars 25% — Is It Enough?

By Will Ashworth, InvestorPlace Contributor
The point is you’re up handsomely betting on a company that’s still got plenty of growth in the tank, not to mention newfound profitability. Trading at 5.2 times sales and expected to reach full-year profitability by 2020, ROKU stock could be ready to launch a second offensive.

Intel Stock Rally Isn’t Over: Here’s Why Prices Above $50 Make Sense

By Luke Lango, InvestorPlace Senior Investment Analyst
For Intel stock, better-than-expected fundamentals are starting to converge on a hugely discounted valuation.

Neurocrine Biosciences Is a Pharma Stock to Watch

By Louis Navellier, Editor, Growth Investor
Biopharma company Neurocrine isn't letting a setback with one of its drugs stop it. Here's what to know about NBIX stock.

Netflix Stock Will Reach $600 Sooner Than You Think

By Luke Lango, InvestorPlace Senior Investment Analyst
The strength and longevity of NFLX's underlying secular growth trends will keep Netflix stock heading higher for years to come.

Dropbox Stock Has a Path to a Rally

By Vince Martin, InvestorPlace Contributor
Dropbox stock has pulled back amid the tech selloff. DBX stock can rally, but investors need to pay close attention to its competition.

5 Strong-Buy Stocks That Crushed 2018

By Harriet Lefton, Writer, TipRanks
Not all stocks lost out in 2018. These are the strong-buy stocks that emerged victorious from a year of extremely volatile trading.

9 A-Rated Safety Stocks for a Grossly Oversold Market

By Louis Navellier, Editor, Growth Investor
There’s no reason to worry if you’re holding the right names in your portfolio. These safety stocks can help you protect your money.

Here’s Why Google Stock Is a Good Bet Regardless of the Market

By Marie Brodbeck, InvestorPlace Contributor
GOOG stock is worth considering for investors who want a long-term tech play that doesn't carry the same high-risk that many competitors do.

AT&T Stock Still Is One of the Best Downturn Plays

By Luke Lango, InvestorPlace Senior Investment Analyst
Given its stable earnings history and anemic valuation, AT&T stock should be relatively resilient to broader market turbulence.

Can Intuitive Surgical Stock Regain Its Momentum?

By Louis Navellier, Editor, Growth Investor
After the tech wreck in 2018, medtech stock Intuitive Surgical still has a bright future. Now is the time to consider ISRG stock.

7 Tech Stocks Without China Exposure

By Luke Lango, InvestorPlace Senior Investment Analyst
Apple issued a warning heard around the world with a Q1 cut, but not all tech stocks are being affected by the warning shot.

Kroger Stock Could Be the Big Underdog Retail Play in 2019

By Will Ashworth, InvestorPlace Contributor
For example, Kroger’s launched a grocery delivery service in Arizona that uses unmanned vehicles to deliver online orders to customers’ homes through a partnership with Nuro, a Silicon Valley autonomous driving startup.

The 3 Best Stocks to Buy At the End of the Bear Market

By Dana Blankenhorn, InvestorPlace Contributor
The best stocks to buy at the bottom of a bear market are those you can see growing over the next three to five years.

Microsoft Stock Is Worth Its Relatively High Price

By Will Healy, InvestorPlace Contributor
Although Microsoft stock is not the cheapest name in tech, the performance of MSFT during the selloff affirms its stability and value.

Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout

By Aaron Levitt, InvestorPlace Contributor
With its Celgene (CELG) buyout, Bristol-Meyers is getting a heck of a deal and will make BMY stock the top-dog cancer medicines.

Why Canopy Growth Stock Should Be in Your Sights

By Nicolas Chahine, InvestorPlace Contributor
Of the whole bunch, CGC stock is the one to buy. This is a long-term bet and Canopy Growth will shrug this Wall Street malaise soon enough.

How to Profit Even If Target Stock Continues to Get No Respect

By Will Healy, InvestorPlace Contributor
Target stock may have become less respected compared to peers, but it offers one key benefit that should profit investors for years to come.

Alcoa Stock Has Been Decimated, But There Is Light Ahead

By Nicolas Chahine, InvestorPlace Contributor
AA stock is well off the Trump trade highs. But this sharp falling wedge in Alcoa is perhaps a great rebound trading opportunity.
Load More Articles